270 related articles for article (PubMed ID: 18768873)
1. Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism.
Shirey KA; Cole LE; Keegan AD; Vogel SN
J Immunol; 2008 Sep; 181(6):4159-67. PubMed ID: 18768873
[TBL] [Abstract][Full Text] [Related]
2. Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity.
Cole LE; Elkins KL; Michalek SM; Qureshi N; Eaton LJ; Rallabhandi P; Cuesta N; Vogel SN
J Immunol; 2006 Jun; 176(11):6888-99. PubMed ID: 16709849
[TBL] [Abstract][Full Text] [Related]
3. Macrophage proinflammatory response to Francisella tularensis live vaccine strain requires coordination of multiple signaling pathways.
Cole LE; Santiago A; Barry E; Kang TJ; Shirey KA; Roberts ZJ; Elkins KL; Cross AS; Vogel SN
J Immunol; 2008 May; 180(10):6885-91. PubMed ID: 18453609
[TBL] [Abstract][Full Text] [Related]
4. Francisella tularensis live vaccine strain folate metabolism and pseudouridine synthase gene mutants modulate macrophage caspase-1 activation.
Ulland TK; Janowski AM; Buchan BW; Faron M; Cassel SL; Jones BD; Sutterwala FS
Infect Immun; 2013 Jan; 81(1):201-8. PubMed ID: 23115038
[TBL] [Abstract][Full Text] [Related]
5. Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.
Cole LE; Mann BJ; Shirey KA; Richard K; Yang Y; Gearhart PJ; Chesko KL; Viscardi RM; Vogel SN
J Leukoc Biol; 2011 Oct; 90(4):787-97. PubMed ID: 21750122
[TBL] [Abstract][Full Text] [Related]
6. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
KuoLee R; Harris G; Conlan JW; Chen W
Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase activation attenuates the TLR2-mediated macrophage proinflammatory cytokine response to Francisella tularensis live vaccine strain.
Medina EA; Morris IR; Berton MT
J Immunol; 2010 Dec; 185(12):7562-72. PubMed ID: 21098227
[TBL] [Abstract][Full Text] [Related]
8. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
[TBL] [Abstract][Full Text] [Related]
9. IKKβ in myeloid cells controls the host response to lethal and sublethal Francisella tularensis LVS infection.
Samaniego S; Marcu KB
PLoS One; 2013; 8(1):e54124. PubMed ID: 23349802
[TBL] [Abstract][Full Text] [Related]
10. Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.
Sebastian S; Pinkham JT; Lynch JG; Ross RA; Reinap B; Blalock LT; Conlan JW; Kasper DL
Vaccine; 2009 Jan; 27(4):597-605. PubMed ID: 19022323
[TBL] [Abstract][Full Text] [Related]
11. Infection with Francisella tularensis LVS clpB leads to an altered yet protective immune response.
Barrigan LM; Tuladhar S; Brunton JC; Woolard MD; Chen CJ; Saini D; Frothingham R; Sempowski GD; Kawula TH; Frelinger JA
Infect Immun; 2013 Jun; 81(6):2028-42. PubMed ID: 23529616
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice.
Zhang P; Katz J; Michalek SM
Mol Immunol; 2009 Feb; 46(4):677-87. PubMed ID: 18929413
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection.
Kurtz SL; Foreman O; Bosio CM; Anver MR; Elkins KL
Infect Immun; 2013 Feb; 81(2):585-97. PubMed ID: 23230288
[TBL] [Abstract][Full Text] [Related]
14. Alternative activation of macrophages and induction of arginase are not components of pathogenesis mediated by Francisella species.
Griffin AJ; Crane DD; Wehrly TD; Scott DP; Bosio CM
PLoS One; 2013; 8(12):e82096. PubMed ID: 24324751
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages.
Cole LE; Shirey KA; Barry E; Santiago A; Rallabhandi P; Elkins KL; Puche AC; Michalek SM; Vogel SN
Infect Immun; 2007 Aug; 75(8):4127-37. PubMed ID: 17517865
[TBL] [Abstract][Full Text] [Related]
16. Immune lymphocytes halt replication of Francisella tularensis LVS within the cytoplasm of infected macrophages.
Bradford MK; Elkins KL
Sci Rep; 2020 Jul; 10(1):12023. PubMed ID: 32694562
[TBL] [Abstract][Full Text] [Related]
17. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
Bakshi CS; Malik M; Mahawar M; Kirimanjeswara GS; Hazlett KR; Palmer LE; Furie MB; Singh R; Melendez JA; Sellati TJ; Metzger DW
Vaccine; 2008 Sep; 26(41):5276-88. PubMed ID: 18692537
[TBL] [Abstract][Full Text] [Related]
18. Mast cell/IL-4 control of Francisella tularensis replication and host cell death is associated with increased ATP production and phagosomal acidification.
Rodriguez AR; Yu JJ; Murthy AK; Guentzel MN; Klose KE; Forsthuber TG; Chambers JP; Berton MT; Arulanandam BP
Mucosal Immunol; 2011 Mar; 4(2):217-26. PubMed ID: 20861832
[TBL] [Abstract][Full Text] [Related]
19. Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon.
Dreisbach VC; Cowley S; Elkins KL
Infect Immun; 2000 Apr; 68(4):1988-96. PubMed ID: 10722593
[TBL] [Abstract][Full Text] [Related]
20. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
Baron SD; Singh R; Metzger DW
Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
